Sean Salmon
Vermogen: 5 M $ op 31-05-2026
Vermogen: 5 M $ op 31-05-2026
Sean Salmon is currently Director at Adagio Medical Holdings, Inc. since 2025.
Formerly, Mr. Salmon was EVP & President of the Diabetes Operating Unit at Medtronic Plc from 2004 to 2021.
Education includes an undergraduate degree from Boston University and an MBA from Kellogg School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MEDTRONIC PLC 0,01% | 16-12-2024 | 64.722 ( 0,01% ) | 5 M $ | 31-05-2026 |
-.--% | 31-03-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Plc
Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau